002907 華森製藥
按盤價 
12.950 +0.080 (+0.622%)
12.950 +0.080 (+0.622%) | 2026/03 - 三個月 | 2025/12 | 2024/12 | 2023/12 | 2022/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 1.920 | 3.884 | 4.682 | 2.026 | 6.842 |
| 總資產報酬率 ROA (%) | 1.614 | 3.300 | 4.072 | 1.759 | 5.409 |
| 投入資產回報率 ROIC (%) | 1.850 | 3.796 | 4.657 | 2.017 | 6.269 | 邊際利潤分析 |
| 銷售毛利率 (%) | 59.935 | 57.387 | 57.274 | 54.978 | 59.335 |
| 營業利潤率 (%) | 17.767 | 11.360 | 12.106 | 6.626 | 13.860 |
| 息稅前利潤/營業總收入 (%) | 16.450 | 8.597 | 10.664 | 4.916 | 14.161 |
| 淨利潤/營業總收入 (%) | 13.646 | 6.675 | 9.903 | 4.728 | 12.532 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 91.879 | 76.650 | 80.253 | 84.081 | 91.697 |
| 價值變動淨收益/利潤總額(%) | 4.415 | 12.516 | 1.474 | -10.910 | -2.407 |
| 營業外收支淨額/利潤總額(%) | -0.102 | -21.311 | -0.384 | -7.071 | -0.544 | 償債能力分析 |
| 流動比率 (X) | 4.679 | 4.269 | 4.864 | 4.742 | 4.528 |
| 速動比率 (X) | 4.151 | 3.743 | 4.203 | 3.938 | 3.985 |
| 資產負債率 (%) | 14.692 | 15.784 | 13.431 | 12.613 | 13.729 |
| 帶息債務/全部投入資本 (%) | 0.583 | 0.643 | -2.047 | -2.368 | -2.329 |
| 股東權益/帶息債務 (%) | 16,568.210 | 14,970.585 | -4,851.382 | -4,206.132 | -4,275.219 |
| 股東權益/負債合計 (%) | 576.723 | 528.585 | 644.531 | 692.802 | 628.379 |
| 利息保障倍數 (X) | -12.661 | -11.201 | -7.638 | -3.865 | 37.741 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 82.647 | 78.356 | 79.963 | 100.525 | 87.211 |
| 存貨周轉天數 (天) | 142.999 | 142.557 | 158.660 | 154.033 | 136.536 |
| 備註： | 報價延遲最少15分鐘，資料更新時間為 19/05/2026 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
